Table 1 Baseline characteristics of patients in the two treatment groups
Losartan+barnidipine | Losartan+lercanidipine | |
|---|---|---|
N | 75 | 76 |
Age (years) | 60.5 ± 8.9 | 60.7 ± 8.8 |
Sex (male/female) | 37/38 | 36/40 |
BMI (Kg/m2) | 28.5 ± 1.3 | 28.2 ± 1.1 |
Duration of diabetes (months) | 9.3 ± 7.2 | 9.1 ± 7.1 |
Duration of hypertension (months) | 6.4 ± 3.6 | 6.3 ± 3.5 |
eGFR (ml/min/1.73 m2) | 84.1 ± 8.5 | 82.5 ± 7.6 |